Concepedia
Psychopharmacology · 2006 · 159 citations · 14 references
Open access
MedicineNeurosciencePharmacologyMolecular PharmacologyNeuropharmacologyPsychopharmacologyAntipsychotic PharmacologyBasal GangliaDopaminergic PharmacologyDopaminergic SignalingLigand BindingNeurotransmissionDopamine Receptor AgonistsDopamine Receptor SubtypesDopaminergic Pathways
14
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Yung-Chi Cheng, William H. Prusoff · Biochemical Pharmacology · 1973 · 12.9K citations
Life Sciences, Biochemistry, Chemical Kinetics +14
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Sean M Renock, Elaine G. Arrington, Louis A. Chiodo et al. · Neuropsychopharmacology · 2003 · 974 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +10
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Bryan L. Roth, Karen Baner, Richard B. Westkaemper et al. · Proceedings of the National Academy of Sciences · 2002 · 780 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +11
A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635
Elaine A. Forster, Ian A. Cliffe, David J. Bill et al. · European Journal of Pharmacology · 1995 · 611 citations
Medicine, Pharmacology, General Pharmacology +8
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
Allan Fletcher, Elaine A. Forster, David J. Bill et al. · Behavioural Brain Research · 1995 · 521 citations
Medicine, Neuroscience, Pharmacology +13